Spyre Therapeutics, Inc.
Developing long-acting antibodies and combinations targeting validated mechanisms in inflammatory bowel disease.
Immunology / IBD · Extended half-life monoclonal antibodies · Clinical (Phase 2)
Developing long-acting antibodies and combinations targeting validated mechanisms in inflammatory bowel disease.
Immunology / IBD · Extended half-life monoclonal antibodies · Clinical (Phase 2)